Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:rizatriptan
|
| gptkbp:approvalYear |
1998
|
| gptkbp:ATCCode |
N02CC04
|
| gptkbp:chemicalFormula |
C15H19N5O
|
| gptkbp:contraindication |
ischemic heart disease
uncontrolled hypertension history of stroke |
| gptkbp:drugClass |
triptan
|
| gptkbp:form |
gptkb:tablet
orally disintegrating tablet |
| https://www.w3.org/2000/01/rdf-schema#label |
Maxalt
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness fatigue drowsiness |
| gptkbp:usedFor |
migraine
|
| gptkbp:bfsParent |
gptkb:MRK
|
| gptkbp:bfsLayer |
5
|